Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
SAF's Profile
Displaying 301-350 of 666 result(s).
CYDY CytoDyn Inc
11/04/2020 1:14:10 PM
There is only one reason people buy (2)
CYDY CytoDyn Inc
11/02/2020 11:19:41 AM
I own both CYDY and RLFTF
CYDY CytoDyn Inc
11/02/2020 11:18:36 AM
I agree. The run up to ten was not (1)
CYDY CytoDyn Inc
10/29/2020 9:31:38 PM
Luck in?
CYDY CytoDyn Inc
10/27/2020 10:49:12 AM
I think all this is about is a fede (4)
CYDY CytoDyn Inc
10/27/2020 10:00:09 AM
Does anyone have an EDUCATED (MD’
CYDY CytoDyn Inc
10/27/2020 9:17:47 AM
Question: What in your opinion woul
CYDY CytoDyn Inc
10/26/2020 5:59:48 PM
The complaints about negative state (8)
CYDY CytoDyn Inc
10/26/2020 5:02:18 PM
Do you really think that the FDA is (1)
CYDY CytoDyn Inc
10/23/2020 6:01:36 PM
Yes...I know...they seem to be the
CYDY CytoDyn Inc
10/23/2020 4:03:04 PM
Glad this week is out of its misery (3)
CYDY CytoDyn Inc
10/23/2020 3:41:43 PM
Yes...I’ve been trading around it
CYDY CytoDyn Inc
10/23/2020 12:10:10 PM
It’s about where the share price (1)
CYDY CytoDyn Inc
10/23/2020 11:57:36 AM
Fair enough on CEO...as far as cash
CYDY CytoDyn Inc
10/23/2020 10:23:15 AM
Based on what you say and your expe (1)
CYDY CytoDyn Inc
10/23/2020 9:16:58 AM
Based on Remdesivir science (accord
CYDY CytoDyn Inc
10/23/2020 9:12:31 AM
Is that what the FDA is going to sa
CYDY CytoDyn Inc
10/23/2020 8:55:52 AM
Agree. It’s up to the FDA. Only t (1)
CYDY CytoDyn Inc
10/23/2020 7:24:48 AM
I am an investor...not a freedom fi (2)
CYDY CytoDyn Inc
10/22/2020 4:08:45 PM
FDA approves Remdesivir...you shoul
CYDY CytoDyn Inc
10/21/2020 8:38:35 AM
Yeah... it’s really not so much a (5)
CYDY CytoDyn Inc
10/21/2020 8:30:12 AM
“ Good point, but would have expo (3)
CYDY CytoDyn Inc
10/21/2020 8:21:04 AM
If I didn’t already have a double (3)
CYDY CytoDyn Inc
10/21/2020 4:16:11 AM
I was in @ .75 / 2016... Agree abou (6)
CYDY CytoDyn Inc
10/21/2020 3:52:19 AM
I own RLFTF as a hedge.
CYDY CytoDyn Inc
10/20/2020 5:16:29 PM
They ADDED the 75% check it was NOT (1)
CYDY CytoDyn Inc
10/20/2020 5:10:01 PM
ADDED...that’s the key!
CYDY CytoDyn Inc
10/20/2020 12:42:52 PM
I think that presupposes that high-
CYDY CytoDyn Inc
10/20/2020 8:56:09 AM
How do people feel funding factors (1)
CYDY CytoDyn Inc
10/20/2020 7:59:08 AM
I agree. At face value it’s hard (1)
CYDY CytoDyn Inc
10/20/2020 6:55:00 AM
Do you think this implies that the
CYDY CytoDyn Inc
10/19/2020 10:07:31 AM
From Seeking Alpha (this is well wr (13)
CYDY CytoDyn Inc
10/18/2020 1:57:08 PM
While that would be great for Cytod (1)
CYDY CytoDyn Inc
10/18/2020 12:13:04 PM
It doesn’t matter what Feuerstein (4)
CYDY CytoDyn Inc
10/18/2020 5:38:22 AM
“ we should consider an expose”
CYDY CytoDyn Inc
10/16/2020 4:10:30 PM
I would probably be described as a (5)
CYDY CytoDyn Inc
10/16/2020 1:40:56 PM
A bit off topic but... What do peop
CYDY CytoDyn Inc
10/16/2020 11:12:05 AM
Here it is... Where we are and wher (5)
CYDY CytoDyn Inc
10/16/2020 10:09:09 AM
I have the same hold time as you… (1)
CYDY CytoDyn Inc
10/16/2020 9:47:00 AM
On the other hand if cydy is alread
CYDY CytoDyn Inc
10/16/2020 9:23:58 AM
I would say short it at your own ri (1)
CYDY CytoDyn Inc
10/16/2020 8:54:39 AM
“Potential” is probably a neces
CYDY CytoDyn Inc
10/16/2020 7:37:15 AM
Question: If DSMC recommended a hal (2)
CYDY CytoDyn Inc
10/15/2020 9:47:47 AM
Ok got it all cause on both arms...
CYDY CytoDyn Inc
10/15/2020 9:38:37 AM
Does anyone know what are the study
CYDY CytoDyn Inc
10/14/2020 11:44:57 PM
Interesting...my estimate is a 9+10 (1)
CYDY CytoDyn Inc
10/14/2020 11:17:52 PM
What do you think SP/ mkt Cap shoul (1)
CYDY CytoDyn Inc
10/14/2020 5:41:44 PM
Keep an eye out for 8K’s (2)
CYDY CytoDyn Inc
10/14/2020 1:33:17 PM
I actually agree with that… The b (3)
CYDY CytoDyn Inc
10/14/2020 8:20:07 AM
Well then...what does that say abou
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Niche Matters: How Focusing Drives RIA Growth and Client Loyalty
  • Significant Movement in Bitcoin as Long-Dormant Wallet Empties
  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site